Toms River-based cancer treatment center to work with thoracic surgeons and pulmonologists to develop customized treatment plans.

1. April 4, 2013
FOR IMMEDIATE RELEASE
CONTACT: Sarah Tiambeng, Zehnder Communications, (504) 962-3731, saraht@z-comm.com
New Jersey CyberKnife Develops Training Program for
Multidisciplinary Approach to Lung Cancer Treatment
Toms River-based cancer treatment center to work with thoracic surgeons and pulmonologists to
develop customized treatment plans
TOMS RIVER, N.J. – Lung cancer patients seeking treatment at New Jersey CyberKnife will soon
experience a more collaborative approach to the planning and delivery of their treatment, including
the participation of not only CyberKnife specialists, but also their referring doctors.
New Jersey CyberKnife at the J. Phillip Citta Regional Cancer Center is developing a CyberKnife
training program to encourage physicians to remain involved in their patients’ care from initial
consultation to post-treatment follow-up.
“The program is aimed at providing better continuity of care for patients with lung cancer and affords
a patient’s doctor ongoing involvement in the treatment process,” said Dr. David D’Ambrosio, medical
director of New Jersey CyberKnife. “This is particularly important for thoracic oncology patients who
can benefit from the continued involvement of the physician with the most knowledge of their medical
history.”
New Jersey CyberKnife treats lung cancer with a procedure called stereotactic body radiation therapy
(SBRT). Using CyberKnife®
technology, radiation is delivered to the targeted tumor location with
pinpoint precision, and radiation exposure to surrounding healthy tissue is minimized. Planning and
delivery of CyberKnife SBRT procedures typically involve specialists from varied backgrounds
working together to determine the most appropriate course of treatment for each patient.
According to Dr. D’Ambrosio, the addition of the CyberKnife training program for lung specialists
supports multidisciplinary collaboration in providing quality patient care.
The new approach will work in combination with hospital partner Community Medical Center’s lung
disease-specific tumor board. Patients who participate in this program are confidentially evaluated by
a multidisciplinary team of experts, including thoracic surgeons, medical and radiation oncologists,
pulmonologists, radiologists, pathologists and nurses from the hospital.
“This is a unique opportunity for lung cancer patients, particularly those with more complex cases,”
said Dr. D’Ambrosio.
New Jersey CyberKnife at the J. Phillip Citta Regional Cancer Center is a service of Community
Medical Center, an affiliate of Barnabas Health. The center is located at 99 Route 37 West in Toms
River, N.J. For more information, call (732) 557-3120.
###